AHA blog: Another unfounded attack on hospitals by ‘shadowy’ Arnold Ventures
Responding to an Arnold Ventures-backed opinion piece in the New England Journal of Medicine attacking tax-exempt hospitals and the 340B program, AHA General Counsel and Secretary Melinda Hatton says the authors’ disclosure form speaks volumes. “Specifically, that it is influenced by a shadowy organization with an obvious bias against hospitals. This article should be understood for what it is: just another attempt by a deep-pocketed organization with a biased agenda to attack hospitals.” READ MORE
Related News Articles
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…